Current Clinical Trials

Stress Urinary Incontinence

You may be able to take part in the study if you are:

• Are a woman at least 18 years of age,

• Still experience urine leakage on effort or exertion, or on sneezing or coughing, at least 2 times a day after surgical treatment,

• Have tried pelvic floor muscle training (PFMT) and received a surgical treatment for SUI, which didn’t resolve your symptoms.

 

​

​

​

 

​​​​​​​​​​​​Stress Urinary Incontinence

Females ages 18-55 diagnosed with stress urinary incontinence with no history of prior treatment may be eligible.

​

​

​

 

Bladder Cancer

A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Subjects with Intermediate Risk (IR) Non-Muscle Invasive Bladder Cancer (NMIBC).

The subjects must have undergone adequate Transurethral Resection of Bladder Tumor (TURBT) during screening with or without peri-operative intravesical chemotherapy within 60 days prior randomization, and must have one of the following, confirmed by a diagnostic pathology report:

• Recurrence within 1 year, low-grade Ta

• Solitary low-grade Ta >3 cm

• Low-grade Ta, multifocal

• High-grade Ta, ≤3 cm

• Low-grade T1

​​

​

​

​​

​Urinary Tract Infection

​Selected participation criteria:​

• Women between the ages 18-75

• Have had at least one UTI in past 12 months

• Have a current UTI

​​

​

​

​

​​​To see if you qualify for one of the above trials, please send us an email.